Quick Answer
DarioHealth Corp. reported Research And Development Expense of $13.79 million for the year ending 2025.
- DarioHealth Corp. showed a decrease of -43.0% in Research And Development Expense from 2024 to 2025.
- This data is from DarioHealth Corp.'s annual report (Form 10-K), filed with the SEC on March 19, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 14 years of available data (2012 to 2025), DarioHealth Corp.'s Research And Development Expense has grown by 818.6%.
- Historical annual values: Fiscal year 2025: $13.79 million | Fiscal year 2024: $24.18 million | Fiscal year 2023: $20.25 million | Fiscal year 2022: $19.65 million | Fiscal year 2021: $17.22 million | Fiscal year 2020: $4.43 million | Fiscal year 2019: $3.69 million | Fiscal year 2018: $3.68 million | Fiscal year 2017: $3.30 million | Fiscal year 2016: $2.15 million | Fiscal year 2015: $2.57 million | Fiscal year 2014: $3.94 million | Fiscal year 2013: $4.91 million | Fiscal year 2012: $1.50 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: